Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

Nature Medicine

Volumn 6, Issue 8, 2000, Pages 886-889

  Yang, Zhi Yong ^a   Duckers, Henricus J ^b   Sullivan, Nancy J ^a   Sanchez, Anthony ^c   Nabel, Elizabeth G ^b   Nabel, Gary J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MUCIN; VIRUS GLYCOPROTEIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DAMAGE; CYTOTOXICITY; EBOLA VIRUS; ENDOTHELIUM CELL; GENE TRANSFER; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; EBOLAVIRUS; ENDOTHELIUM, VASCULAR; GLYCOPROTEINS; HEMORRHAGIC FEVER, EBOLA; HUMANS; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EBOLA VIRUS; PRIMATES; RNA VIRUSES; SUIDAE;

EID: 0033831191     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/78645     Document Type: Article

References (18)

1. Bowen, E.T.W. et al. Viral haemorrhagic fever in southern Sudan and northern Zaire. Lancet 1, 571-573 (1977).
2. Centers for Disease Control. Outbreak of Ebola viral hemorrhagic fever - Zaire. Morbid. Mortal. Wkly. Rep. 44, 381-382 (1995).
3. Peters, C.J., Sanchez, A., Rollin, P.E., Ksiazek, T.G. & Murphy, F.A. in Fields Virology (eds. Fields, B.N., Knipe, D.M. & Howley, P.M.) 1161-1176 (Lippincott-Raven, Philadelphia, 1996).
4. Baskerville, A., Bowen, E.T.W., Platt, G.S., McArdell L.B. & Simpson, D.I.H. The pathology of experimental Ebola virus infection in monkeys. J. Pathology 125, 131-138 (1978).
5. Baskerville, A., Fisher-Hoch, S.P., Neild, G.H. & Dowsett, A.B. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J. Pathology 147, 199-209 (1985).
6. Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70, 2208-2214 (1996).
7. Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nature Med 5, 423-426 (1999).
8. Villinger F. et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179, S188-191 (1999).
9. Yang, Z. et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279, 1034-1037 (1998).
10. Sanchez, A. et al. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72, 6442-6447 (1998).
11. Weissenhorn, W., Calder, L.J., Wharton, S.A., Skehel, J.J. & D. C. Wiley. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 95, 6032-6036 (1998).
12. Volchkov, V.E., Feldmann, H., Volchkova, V.A. & Klenk, H.-D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95, 5762-5767 (1998).
13. Xu, L. et al. Immunization for Ebola virus infection. Nature Med. 4, 37-42 (1998).
14. Mbiene, J.P., Maccallum, D.K. & Mistretta, C.M. Organ cultures of embryonic rat tongue support tongue and gustatory papilla morphogenesis in vitro without intact sensory ganglia. J. Comp. Neurol. 377, 324-340 (1997).
15. Yang, S. et al. Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10, 123-132 (1999).
16. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad Sci. USA 90, 8392-8396 (1993).
17. Feldmann, H., Nichol, S.T., Klenk, H.D., Peters, J. & Sanchez, A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199, 469-473 (1994).
18. Ohno, T. et al. Gene therapy for vascular smooth muscle cell proliferation following arterial injury. Science 265, 781-784 (1994).